Watch ONCY. Know when insiders buy.
One email the day a filing lands. Free.
ONCY
ONCOLYTICS BIOTECH INC
0.68
+0.00 +0.00%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
71
PASS · shorts 71
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $86.7MP/E —DIV YIELD —FCF YIELD -23.20%REV TTM —NET INCOME −$28.8MNET CASH —52W 0.68 – 1.42SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$9.4M | −$9.4M | — | -0.08 | −$8.1M | $0 | −$8.1M | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$9.3M | −$9.2M | — | -0.08 | −$7.3M | $6K | −$7.3M | May 14 |
| Q2 2025 · Jun 30 | — | — | — | −$4.7M | −$5.3M | — | -0.06 | −$4.1M | $0 | −$4.1M | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$5M | −$4.7M | — | -0.06 | −$4.7M | $1K | −$4.7M | May 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$28.7M | −$28.8M | — | -0.30 | −$20.1M | $6K | −$20.1M | — | — |
| FY2024 · to Dec 31 | — | — | −$25.5M | −$22.8M | — | -0.30 | −$19.9M | $174K | −$20.1M | — | — |
Every number comes from ONCOLYTICS BIOTECH INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.